Biotechnology Market

Market Overview:

The global biotechnology market size reached USD 761.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 1,315.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.27% during 2025-2033. The increasing research and development (R&D) in personalized medicine, numerous advancements in genetic engineering, and escalating demand for sustainable agriculture are some of the major factors propelling the market.

Biotechnology is a multidisciplinary science that uses live creatures, cells, and biological systems to create novel goods and technologies. It entails using biological processes and creatures at the molecular and cellular levels to address problems in industries such as healthcare, agriculture, and environmental management. Biotechnology includes genetic engineering, biopharmaceuticals, bioinformatics, and synthetic biology, all of which attempt to develop new solutions, improve current processes, and further our knowledge of biological systems. This field has a significant impact on contemporary medicine, sustainable agriculture, and the production of new materials for a variety of purposes.

Innovation as the Primary Market Growth Catalyst

The increasing innovation in fields, such as gene editing, personalized medicine, and new treatments, because of high growth in genetic research and knowledge of molecular biology, will drive the market growth over the forecast period. Additionally, the high incidence of chronic diseases and the necessity for drug-specific treatments have increased the demand for biopharmaceuticals and precision medicine, thereby positively impacting the market growth. Also, the increasing need for sustainable farming solutions due to the growing world population and availability of limited cultivable land has fueled the growth in adopting biotechnological methods in improving crops and biopesticides. Besides this, the intersection of information technology with biotechnology, which is referred to as bioinformatics, that optimizes information-driven perceptions for research and development is driving the market forward. Additionally, the establishment of bioremediation technologies and biofuels due to the increasing emphasis on sustainability in the environment is driving market growth.

Biotechnology Market Trends/Drivers:

Rapid advancements in genetic engineering

The remarkable progress in genetic engineering, prominently exemplified by the revolutionary CRISPR-Cas9 technology, represents a primary driver in the biotechnology market. This technique allows scientists to precisely modify genes within organisms, presenting unprecedented potential for applications in medicine, agriculture, and industrial processes. In healthcare, genetic engineering facilitates the development of innovative gene therapies for genetic disorders and cancers, offering promising avenues for personalized treatments. Moreover, the ability to engineer microbes for the production of valuable compounds like insulin and enzymes has transformed pharmaceutical and industrial manufacturing.

Increasing demand for personalized medicine and therapeutics

The concept of personalized medicine, tailored to an individual's genetic makeup, is gaining traction in the biotechnology market. Advancements in genomic sequencing technologies have made it possible to analyze an individual's genetic code and identify genetic variations linked to diseases. This has led to the development of targeted therapies that address the unique genetic characteristics of patients, enhancing treatment efficacy and reducing adverse effects. Biotechnology enables the production of biopharmaceuticals such as monoclonal antibodies and gene therapies, aligning with the principles of personalized medicine. Additionally, diagnostics based on genetic markers allow for early disease detection and prognosis, reshaping healthcare practices toward more precise and individualized approaches.

Rising need for sustainable agriculture solutions

The increasing global demand for food, coupled with environmental concerns and the need for sustainable agricultural practices, fuels the adoption of biotechnological solutions in farming. Genetically modified crops (GMOs) engineered for enhanced yield, pest resistance, and nutritional content are examples of biotechnology's influence on agriculture. Biopesticides derived from naturally occurring organisms are gaining preference over traditional chemical pesticides owing to their reduced environmental impact. Biotechnology offers tools to optimize plant traits, improve crop resilience to climate change, and increase nutrient efficiency, contributing to food security and resource sustainability. This driver reflects the critical role of biotechnology in addressing pressing challenges within the agriculture sector while minimizing ecological footprints.

Biotechnology Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global biotechnology market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on product type, technology, and application.

Breakup by Product Type:

• Instruments
• Reagents
• Software and Services
   

The report has provided a detailed breakup and analysis of the market based on the product type. This includes instruments, reagents, and software and services.

Instruments form the foundation of advanced research and diagnostics, enabling precise analysis and experimentation. Reagents are essential components that fuel experimental processes, facilitating accurate results and breakthroughs. Software plays a pivotal role, providing data analysis, visualization, and integration solutions, enhancing efficiency and accuracy in biotechnological endeavors. Services encompass consulting, training, and technical support, nurturing collaboration and aiding in the effective utilization of tools.

Furthermore, these components synergistically push the boundaries of biotechnology, fostering innovation and driving advancements that impact diverse sectors such as healthcare, agriculture, and environmental sciences. As the industry evolves, the strategic interplay of instruments, reagents, software, and services continues to shape the trajectory of biotechnology, fueling growth, discovery, and progress.

Breakup by Technology:

• Nanobiotechnology
• Tissue Engineering and Regeneration
• DNA Sequencing
• Cell-Based Assays
• Fermentation
• PCR Technology
• Chromatography
• Others

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes nanobiotechnology, tissue engineering and regeneration, DNA sequencing, cell-based assays, fermentation, PCR technology, chromatography, and others. 

Nanobiotechnology integrates nanoscale materials with biological systems, revolutionizing drug delivery, diagnostics, and therapies. Tissue engineering and regeneration pioneers novel approaches for creating functional tissues, addressing organ shortages and medical needs. DNA sequencing enables comprehensive genomic analysis, guiding personalized medicine and disease understanding. Cell-based assays provide insights into cellular behavior, supporting drug development and toxicity testing. Fermentation is a cornerstone for bioprocessing, producing biofuels, pharmaceuticals, and enzymes. PCR Technology amplifies DNA, underpinning diagnostics and genetic research.

Chromatography separates biomolecules with precision, crucial in drug purification and analytical processes. These intertwined advancements drive the market's progress, fostering innovation and solutions across healthcare, agriculture, and environmental sectors.

Breakup by Application:

• Healthcare
• Food and Agriculture
• Natural Resources and Environment
• Industrial Processing
• Bioinformatics
• Others
   

Healthcare dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes healthcare, food and agriculture, natural resources and environment, industrial processing, bioinformatics, and others. According to the report, healthcare represented the largest segment.

Healthcare serves as a pivotal driving force behind the biotechnology market, catalyzing innovations that transform patient care and medical practices. Biotechnology solutions play a vital role in diagnostics, treatment development, and personalized medicine. From advanced DNA sequencing enabling precise disease identification to biopharmaceuticals revolutionizing treatment modalities, the synergy between healthcare and biotechnology yields breakthrough therapies, improved patient outcomes, and enhanced disease management.

As healthcare and biotechnology intertwine, novel discoveries in areas such as gene editing, synthetic biology, and biomarker development further propelling the market growth. The biotechnology sector's continual evolution addresses current medical challenges and paves the way for future advancements, shaping the landscape of healthcare delivery and underscoring its significance as a critical driver of progress within the biotechnology domain.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market since the region boasts a robust ecosystem of research, innovation, and industry collaboration. The region's strong investment in research and development (R&D), coupled with its well-established regulatory frameworks, fosters an environment conducive to biotechnological breakthroughs. Various leading universities, research institutions, and biotech companies converge to push the boundaries of scientific discovery and technological advancements.

Furthermore, the rising emphasis of the North America region on entrepreneurship and venture capital further accelerates the commercialization of novel biotech solutions. With a history of pioneering achievements in areas such as genomics, pharmaceuticals, and medical devices, North America's influential role continues to shape the global biotechnology landscape, catalyzing growth, fostering innovation, and driving positive societal and economic impacts. In June 2025, the NSCEB initiated its 'Biotech Across America' roadshow in North Carolina, a leading biotechnology hub. The visit highlighted the state's robust biopharma manufacturing, workforce development, and agricultural biotech innovations. Discussions emphasized strengthening U.S. leadership in biotechnology for national security, economic resilience, and domestic supply chain onshoring, underscoring the industry's rapid growth and pivotal role in shaping the future.

Competitive Landscape:

Key players in the biotechnology market have introduced groundbreaking innovations. Leading biopharmaceutical companies are developing mRNA-based vaccines that demonstrated remarkable efficacy in pandemic response. Additionally, advancements in CRISPR-based gene editing techniques have enabled precise and efficient modifications in various organisms, promising transformative applications in genetic therapies and modified crops. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in drug discovery and development processes is accelerating the identification of potential drug candidates. These innovations reflect the industry's commitment to addressing global challenges, ranging from disease outbreaks to food security, through cutting-edge biotechnological solutions with the potential to reshape medical treatments, agriculture practices, and industrial processes. We also expect the market to witness new entrants, consolidation of portfolios, and an increase in strategic partnerships and collaborations among vendors to drive healthy competition within the domain during the forecast period. 

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Amgen Inc.
• Biocon Limited
• Biogen Inc.
• F. Hoffmann-La Roche AG
• Genmab A/S
• Lonza Group AG
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Seagen Inc.
• Syngenta AG
• Vertex Pharmaceuticals Incorporated
   

Recent Developments:

• In May 2025, Biogen and City Therapeutics partnered to develop new RNA interference (RNAi) therapies targeting central nervous system diseases. City Therapeutics would apply its RNAi platform and Biogen’s delivery tech to create a systemic RNAi treatment. Biogen would lead clinical development, regulatory submissions, and commercialization. This collaboration marks a significant step in expanding RNAi applications in biotech, with a focus on advancing novel treatments for neurological conditions.
• In May 2025, Biocon Biologics, through its partner Yoshindo Inc., launched Ustekinumab BS Subcutaneous Injection [YD] in Japan, a biosimilar to Stelara. Developed and manufactured by Biocon Biologics, the biosimilar targets psoriasis vulgaris and psoriatic arthritis. This marks Biocon’s continued expansion in global biosimilar markets and strengthens its footprint in Japan’s biologics sector, with a focus on monoclonal antibody-based therapies.
• In April 2025, Novartis announced plans to invest USD 23 Billion over five years to boost its US biotech and pharmaceutical footprint. The plan includes seven new facilities, 1,000 direct jobs, and 4,000 additional US roles. Most facilities would focus on biologics drug substances and packaging. A new San Diego research hub and expanded radioligand therapy sites signal strong momentum in biotech manufacturing and innovation, reinforcing Novartis’s US market commitment.
• In April 2025, Amgen invested an additional USD 900 Million to expand its Ohio biologics manufacturing site, raising its total spend in Central Ohio to over USD 1.4 Billion. The expansion would bring the total number of jobs at the site to 750. Amgen, a US biologics manufacturing leader since 1988, cited Ohio’s favorable business climate and location as key factors for deepening its presence in the region.
• In March 2025, Roche opened the Roche Genentech Innovation Center Boston at Harvard’s Enterprise Research Campus in Allston. The site would lead R&D in cardiovascular, renal, and metabolism (CVRM) diseases and support AI-driven drug discovery. Serving as a major U.S. innovation hub, the center could employ up to 500 people. It deepens Roche’s collaboration with Harvard and expands its capabilities in biologics and data science-led biotech research.

Biotechnology Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the biotechnology market from 2019-2033.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global biotechnology market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the biotechnology industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.